Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avinger, Inc. stock logo
AVGR
Avinger
$0.47
$0.47
$0.36
$2.07
$1.57M1.091.25 million shsN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.10
$0.09
$0.08
$0.39
$1.02M0.517,981 shs95 shs
NVIVQ
Invivo Therapeutics
$0.37
$0.37
$0.00
$0.00
$1.15M0.4N/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
$1.15
$1.26
$1.00
$19.94
$493K1.51,027 shsN/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avinger, Inc. stock logo
AVGR
Avinger
0.00%0.00%0.00%0.00%-70.56%
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00%+18.54%+17.81%-18.38%-74.14%
NVIVQ
Invivo Therapeutics
0.00%0.00%0.00%0.00%+36,999,900.00%
Sonendo, Inc. stock logo
SONX
Sonendo
0.00%-8.00%-4.17%-35.39%+1,116.42%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avinger, Inc. stock logo
AVGR
Avinger
N/AN/AN/AN/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/AN/AN/AN/A
NVIVQ
Invivo Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
1.0882 of 5 stars
0.05.00.00.02.80.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avinger, Inc. stock logo
AVGR
Avinger
0.00
N/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00
N/AN/AN/A
NVIVQ
Invivo Therapeutics
0.00
N/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avinger, Inc. stock logo
AVGR
Avinger
$7.26M0.22N/AN/A($4.53) per share-0.10
Dynatronics Co. stock logo
DYNT
Dynatronics
$33.60M0.03N/AN/A$0.57 per share0.17
NVIVQ
Invivo Therapeutics
N/AN/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
$44.40M0.01N/AN/A$89.42 per share0.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avinger, Inc. stock logo
AVGR
Avinger
-$18.32M-$11.06N/AN/AN/A-261.06%-5,527.11%-123.25%8/6/2025 (Estimated)
Dynatronics Co. stock logo
DYNT
Dynatronics
-$2.70M-$0.78N/AN/A-8.35%-41.81%-9.56%N/A
NVIVQ
Invivo Therapeutics
-$10.49MN/A0.00N/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
-$60.92M-$59.12N/AN/A-92.74%-184.01%-68.60%8/8/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avinger, Inc. stock logo
AVGR
Avinger
N/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
NVIVQ
Invivo Therapeutics
N/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avinger, Inc. stock logo
AVGR
Avinger
N/A
1.21
0.81
Dynatronics Co. stock logo
DYNT
Dynatronics
0.25
1.21
0.60
NVIVQ
Invivo Therapeutics
N/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
0.55
1.82
1.22

Institutional Ownership

CompanyInstitutional Ownership
Avinger, Inc. stock logo
AVGR
Avinger
18.30%
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
NVIVQ
Invivo Therapeutics
12.32%
Sonendo, Inc. stock logo
SONX
Sonendo
28.68%

Insider Ownership

CompanyInsider Ownership
Avinger, Inc. stock logo
AVGR
Avinger
42.80%
Dynatronics Co. stock logo
DYNT
Dynatronics
7.98%
NVIVQ
Invivo Therapeutics
2.45%
Sonendo, Inc. stock logo
SONX
Sonendo
7.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avinger, Inc. stock logo
AVGR
Avinger
703.31 million1.89 millionNot Optionable
Dynatronics Co. stock logo
DYNT
Dynatronics
20010.62 million8.11 millionNot Optionable
NVIVQ
Invivo Therapeutics
63.11 million3.03 millionN/A
Sonendo, Inc. stock logo
SONX
Sonendo
250429,000393,000Not Optionable

Recent News About These Companies

Sonendo Inc.
Sonendo, Inc. (SONX) Q2 2024 Earnings Call Transcript
Here's what Wall Street expects from Sonendo's earnings report
Sonendo, Inc. (SONX)

Media Sentiment Over Time

Avinger stock logo

Avinger NASDAQ:AVGR

$0.47 0.00 (0.00%)
As of 06/13/2025

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.

Dynatronics stock logo

Dynatronics NASDAQ:DYNT

$0.10 0.00 (0.00%)
As of 06/13/2025

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Invivo Therapeutics NASDAQ:NVIVQ

$0.37 0.00 (0.00%)
As of 07/26/2024

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Sonendo stock logo

Sonendo NYSE:SONX

$1.15 0.00 (0.00%)
As of 06/13/2025

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.